Somatic frameshift mutation of the calreticulin gene (CALR) is another MPN-restricted key driver mutation found in 67% and 88% of patients with essential thrombocythemia and primary myelofibrosis respectively [114]. This evidence concerns the gene CALR and myeloproliferative neoplasm.